Heart Disease News and Research

Latest Heart Disease News and Research

Cocoa and blood pressure: an interview with Dr Karin Ried

The compounds in cocoa responsible for blood pressure reduction are called flavanols or polyphenols. Flavanols are also found in green tea, dark berries or red wine.

24 Aug 2012

Study demonstrates how DBP production is modulated by daily variations of temperature

Numerous processes in our body fluctuate in a regular pattern during the day. These circadian (or daily) variations can be driven by local oscillators present within our cells or by systemic signals controlled by the master pacemaker, located in the brain. Ueli Schibler, professor at the University of Geneva (UNIGE), Switzerland, unveils a molecular mechanism by which body temperature rhythms influence the expression of 'clock genes' and synchronize local oscillators.

24 Aug 2012

Parental methylated histones not transferred to daughter DNA

It's widely accepted that molecular mechanisms mediating epigenetics include DNA methylation and histone modifications, but a team from Thomas Jefferson University has evidence to the contrary regarding the role of histone modifications.

24 Aug 2012

Scientists develop reliable method to convert adult blood cells into iPSCs

Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body.

24 Aug 2012

Viewpoints: Cantaloupes and food safety; Diversity in health incentives

People don't ordinarily think of cantaloupes as killers, but over the last two summers 32 Americans have died after eating contaminated pieces of the popular fruit. ... Government is hyper-vigilant about terror attacks and problem airliners, which is good, but not so much about food - at least if you judge by the time it's taking the Obama administration to release new rules intended to prevent exactly the sort of food-borne outbreaks cantaloupes have caused.

24 Aug 2012

Bristol-Myers Squibb terminates BMS-986094 Phase II development for treatment of hepatitis C

Bristol-Myers Squibb Company announced today that the Company has discontinued development of BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibitor that was in Phase II development for the treatment of hepatitis C.

24 Aug 2012

MOZ protein could explain variations in severity of DiGeorge syndrome

The discovery of a 'switch' that modifies a gene known to be essential for normal heart development could explain variations in the severity of birth defects in children with DiGeorge syndrome.

24 Aug 2012

Roundup: Ore. lawmakers examine 'disclosure' as way to limit malpractice claims; $2.8M in fraudulent public assistance given in Mass.; Md. exchange announcement Thursday

Lawmakers are expected to take up tort reform when the Oregon Legislature convenes next February. To get those discussions moving, a Patient Safety and Defensive Medicine Workgroup is developing draft legislation that includes issues such as confidentiality, mediation, dispute resolution, litigation, discovery and patient safety. Disclosure -- informing patients when a serious medical event has occurred in a hospital setting -- is also on the table.

24 Aug 2012

Concern over ameba-infested tap water deaths

People with sinusitis who regularly treat their condition using nasal irrigation should be aware of a potential contamination risk associated with using inadequately filtered tap water, say US researchers.

23 Aug 2012

Nicotine dependence risk increased in bipolar disorder

Adults with mood and anxiety disorders are significantly more likely to be smokers than the general population, a US study of data from the National Epidemiologic Survey of Alcohol and Related Conditions shows.

23 Aug 2012

Women with heart attack symptoms receive lower quality of care than men

A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.

23 Aug 2012

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

23 Aug 2012

Positron submits Drug Master File with FDA for production of API grade Sr-82

Positron Corporation, a leading molecular imaging healthcare company, is pleased to announce the submission of a Drug Master File (DMF), with the Federal Drug Administration (FDA), for the production of Active Pharmaceutical Ingredient (API) grade strontium-82, through its wholly owned subsidiary Manhattan Isotope Technology, LLC.

23 Aug 2012

Diabetes risk may be higher in childhood cancer survivors who received radiotherapy

Childhood cancer survivors who underwent radiotherapy treatment that exposed their pancreas to radiation may be at higher risk of developing diabetes in later life, according to an Article published Online First in The Lancet Oncology.

23 Aug 2012

Blood clotting treatment algorithms help decrease transfusion requirements in cardiac surgery patients

In patients who undergo cardiac surgery, severe perioperative bleeding and its treatment are often associated with increases in major cardiac and non-cardiac adverse events and greater mortality. A study from the September issue of Anesthesiology determined certain blood clotting treatment algorithms helped decrease blood transfusion requirements in cardiac surgery patients and were associated with improved outcomes and hospital cost-savings.

23 Aug 2012

Power Over Pressure steering committee launches world's first hypertension online resource

The Power Over Pressure steering committee today announced the launch of the world's first online resource created to help healthcare professionals improve diagnosis and develop solutions for treatment-resistant hypertension, an urgent and growing public health issue that affects 120 million people worldwide.

23 Aug 2012

Statin's potency may cause muscle problems in patients with cardiovascular disease

A study from the University of California, San Diego School of Medicine, published August 22 online by PLoS ONE, reports that muscle problems reported by patients taking statins were related to the strength or potency of the given cholesterol-lowering drugs.

23 Aug 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Cocoa and blood pressure: an interview with Dr Karin Ried

Study demonstrates how DBP production is modulated by daily variations of temperature

Parental methylated histones not transferred to daughter DNA

Scientists develop reliable method to convert adult blood cells into iPSCs

Viewpoints: Cantaloupes and food safety; Diversity in health incentives

Bristol-Myers Squibb terminates BMS-986094 Phase II development for treatment of hepatitis C

MOZ protein could explain variations in severity of DiGeorge syndrome

Roundup: Ore. lawmakers examine 'disclosure' as way to limit malpractice claims; $2.8M in fraudulent public assistance given in Mass.; Md. exchange announcement Thursday

Concern over ameba-infested tap water deaths

Nicotine dependence risk increased in bipolar disorder

Women with heart attack symptoms receive lower quality of care than men

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

Positron submits Drug Master File with FDA for production of API grade Sr-82

Diabetes risk may be higher in childhood cancer survivors who received radiotherapy

Blood clotting treatment algorithms help decrease transfusion requirements in cardiac surgery patients

Power Over Pressure steering committee launches world's first hypertension online resource

Statin's potency may cause muscle problems in patients with cardiovascular disease

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

NIH awards $100,000 STTR Phase I Grant to Transgenomic for pancreatic cancer research

Downward trend for heart failure in Canada

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in